A Multi-state Model for Designing Clinical Trials for Testing Overall Survival Allowing for Crossover after Progression.

about

A Multi-state Model for Designing Clinical Trials for Testing Overall Survival Allowing for Crossover after Progression.

Item

http://www.wikidata.org/entity/Q42763247

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

A Multi-state Model for Design ...... r Crossover after Progression.

@en

A Multi-state Model for Design ...... r Crossover after Progression.

@nl

type

Item

label

A Multi-state Model for Design ...... r Crossover after Progression.

@en

A Multi-state Model for Design ...... r Crossover after Progression.

@nl

prefLabel

A Multi-state Model for Design ...... r Crossover after Progression.

@en

A Multi-state Model for Design ...... r Crossover after Progression.

@nl

P1476

A Multi-state Model for Design ...... or Crossover after Progression

@en

P2093

Stephen L George

http://www.w3.org/2001/XMLSchema#string

Xiaofei Wang

http://www.w3.org/2001/XMLSchema#string

P2860

The versatility of multi-state models for the analysis of longitudinal data with unobservable features.

Multi-state models: a review.

Modeling the relationship between progression-free survival and overall survival: the phase II/III trial.

Detecting an overall survival benefit that is derived from progression-free survival

Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies.

Longer-term outcomes of letrozole versus placebo after 5 years of tamoxifen in the NCIC CTG MA.17 trial: analyses adjusting for treatment crossover.

Estimating treatment effects with treatment switching via semicompeting risks models: an application to a colorectal cancer study.

Tutorial in biostatistics: competing risks and multi-state models.

The hazards of hazard ratios.

Joint modeling of progression-free survival and death in advanced cancer clinical trials.

P304

12-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/19466315.2015.1093539

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Fang Xia

P577

2016-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27239255

http://www.w3.org/2001/XMLSchema#string

P932

4879617

http://www.w3.org/2001/XMLSchema#string